Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
Katarina Le Blanc1, Francesco Frassoni2, Lynne Ball3, Franco Locatelli4, Helene Roelofs5, Ian Lewis6, Edoardo Lanino7, Berit Sundberg1, Maria Ester Bernardo4, Mats Remberger1, Giorgio Dini7, R Maarten Egeler3, Andrea Bacigalupo2, Willem Fibbe5, Olle Ringdén1
1Haematology Centre and Centre of Allogeneic Stem Cell Transplantation, Division of Clinical Immunology, Karolinska University Hospital, Huddinge, Stockholm, Sweden
2Centro Cellule Staminali e Terapia Cellulare e Divisione Ematologia, Ospedale San Martino, Genova, Italy
3Department of Paediatrics, Leiden University Medical Centre, Leiden, Netherlands
4Onco-Ematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Italy
5Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, Netherlands
6Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
7Dipartimento di Ematologia e Oncologia, IRCCS G Gaslini, Genova, Italy
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
The Lancet
Tập 371
1579-1586
Thông tin tác giả